Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Custom Recombinant Antibody Production | Biorbyt
Custom Recombinant Antibody Production Banner
 

Custom Recombinant Antibody Production

Custom recombinant antibody production involves generating sequence-defined antibodies using advanced recombinant DNA and cell culture technologies. The process typically begins with identifying antibody variable region genes from immunized donors or synthetic phage libraries. These genes are engineered into optimized expression vectors and expressed in high-yield mammalian cells (CHO/HEK293) or bacterial hosts, yielding batch-to-batch consistent recombinant antibodies for critical diagnostic and therapeutic applications.

Advantages of Biorbyt's Recombinant Antibodies

High Specificity

Recombinant antibodies engineered by Biorbyt exhibit exceptionally high binding specificity due to precise target epitope selection, significantly minimizing background cross-reactivity and off-target binding.

Full Customization

Biorbyt provides fully tailored production packages, enabling precise selection of antibody parameters including species isotype, Fc-fusion domains, affinity maturation, and reporter dye conjugations.

Scalability & Consistency

Our recombinant manufacturing platform seamlessly scales from milligram research quantities to gram-level industrial lots while maintaining zero genetic drift and permanent lot-to-lot reproducibility.

Reduced Animal Use

By leveraging sequence-based recombinant expression vectors, our workflow significantly reduces or eliminates animal use during long-term production runs, supporting sustainable research initiatives.

Custom Recombinant Antibody Production Process Flowchart

Service Process & Deliverables

Peptide Immunogen

Lead Time: 10 – 16 Weeks

Recombinant Protein

Lead Time: 12 – 16 Weeks

Native Protein

Lead Time: 12 – 16 Weeks

Workflow Process

  1. Positive target gene selection & vector construction
  2. Recombinant antibody expression in CHO/HEK293 cells
  3. Protein A/G affinity chromatography purification
  4. ELISA and Western blot (WB) validation screening

Key Deliverables

  • Comprehensive Quality Control (QC) report for immunogen target
  • 100 µg purified recombinant antibody with full COA (includes sequence data, concentration, purity, and endotoxin levels)
  • Guaranteed WB positive validation against target immunogen
  • Additional application testing available upon request (IHC, IF, IP, Flow Cytometry)
 

*By pressing "SUBMIT" you are agreeing to Biorbyt storing the information provided and contacting you in line with our privacy policy.

Please reach out to us at [email protected] to discuss your request for . Our scientists are here to answer your questions and provide you with the information and expertise you need for your projects.